{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:36:02Z","timestamp":1793111762722,"version":"4.5.0"},"reference-count":88,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Delivery"],"published-print":{"date-parts":[[2026,9,2]]},"DOI":"10.1080\/20415990.2026.2742638","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:10:34Z","timestamp":1791274234000},"page":"1017-1028","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["An evaluation of mitapivat for the treatment of non-transfusion-dependent alpha- and beta-thalassemia"],"prefix":"10.1080","volume":"17","author":[{"given":"Aaron N.","family":"Cheng","sequence":"first","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine","place":["Philadelphia, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanny","family":"Al-Samkari","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27621"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.066845"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2023.101165"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2006.04.005"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)92175-5"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08220.x"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27194"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00635-X"},{"key":"e_1_3_4_11_1","unstructured":"FDA approves first oral treatment for anemia in thalassemia an inherited blood disorder. U.S. Food & Drug Administration; [cited 2026 Mar 26]. Available from: https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-first-oral-treatment-anemia-thalassemia-inherited-blood-disorder"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(12)70003-6"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-251348"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2015.1091942"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2026020059"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-397729"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-07-815928"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2023000468"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.754638"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-129996"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb05072.x"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2012.02.003"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-019-03659-1"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.1.36"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(12)70007-3"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12211"},{"key":"e_1_3_4_27_1","volume-title":"Guidelines for the management of non-transfusion-dependent \u03b2-thalassaemia","author":"Taher AT","year":"2023","unstructured":"Taher AT, Musallam KM, Cappellini MD. Guidelines for the management of non-transfusion-dependent \u03b2-thalassaemia. 3rd ed. Nicosia (Cyprus): Thalassaemia International Federation; 2023 [cited 2026 Apr 7]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK599489\/","edition":"3"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2010.07.006"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2012.06.001"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2019.026"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v88i4.6837"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04370-2"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26428"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04456-5"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtumed.2023.05.002"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.18502\/ijph.v51i1.8287"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2011.05.013"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-210112"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2010.01509.x"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.079970"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02983382"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-004-1002-4"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20640"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2000.02376.x"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03940.x"},{"issue":"1","key":"e_1_3_4_46_1","first-page":"455","article-title":"Long-term hemoglobin improvements in non-transfusion-dependent alpha- or beta-thalassemia: results from the open-label extension of the ongoing phase 3 energize trial","volume":"10","author":"Al-Samkari H","year":"2026","unstructured":"Al-Samkari H, Czapla L, Estepp JH, et al. Long-term hemoglobin improvements in non-transfusion-dependent alpha- or beta-thalassemia: results from the open-label extension of the ongoing phase 3 energize trial. Hemasphere. 2026;10(1):455\u2013456.","journal-title":"Hemasphere"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00208-3"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025016554"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013767.pub2"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10-408021"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2017.02.002"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.3109\/08880010903271671"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2012.07.021"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/20406207211066070"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2022.2125865"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.240846"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25926"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13572"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2023.2290746"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902678"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00377-0"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116634"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00214-9"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI144206"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008635"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.172656"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27442"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.31440"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm-2026-1-0021"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004675"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27312"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26830"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011743"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.282884"},{"key":"e_1_3_4_75_1","unstructured":"Aqvesme Drug Label. Food and Drug Administration. [cited 2026 Jul 13]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/216196s003lbl.pdf"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-753525"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.238865"},{"issue":"1","key":"e_1_3_4_78_1","first-page":"298","article-title":"Preclinical pharmacokinetic\/pharmacodynamic relationships for AG-348, an investigational small-molecule activator of pyruvate kinase","volume":"100","author":"Chen Y","year":"2015","unstructured":"Chen Y, Kosinski PA, Histen G, et al. Preclinical pharmacokinetic\/pharmacodynamic relationships for AG-348, an investigational small-molecule activator of pyruvate kinase. Haematologica. 2015;100(S1):298\u2013299.","journal-title":"Haematologica"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.604"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13609"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01337-X"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.20058"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01416.x"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1080\/03630269.2022.2072320"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.44386"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.7.2606"},{"issue":"1","key":"e_1_3_4_87_1","first-page":"476","article-title":"Effects of mitapivat on iron burden and spleen size in erythrocyte membranopathies and congenital dyserythropoietic anemia type ii: 56-week follow-up results from the satisfy study","volume":"10","author":"Doeven T","year":"2026","unstructured":"Doeven T, Van Beers EJ, Van Wijk R, et al. Effects of mitapivat on iron burden and spleen size in erythrocyte membranopathies and congenital dyserythropoietic anemia type ii: 56-week follow-up results from the satisfy study. Hemasphere. 2026;10(S1):476\u2013477.","journal-title":"Hemasphere"},{"issue":"1","key":"e_1_3_4_88_1","first-page":"3978","article-title":"RoxyScan assesses pyruvate kinase activator\u2019s effect on oxidative stress sensitivity in \u00df-thalassemia patients: an ancillary study of the ENERGIZE\/ENERGIZE-T clinical trials","volume":"9","author":"Hernandez Quiroga C","year":"2025","unstructured":"Hernandez Quiroga C, Saes J, Eijkelenboom-Bos J, et al. RoxyScan assesses pyruvate kinase activator\u2019s effect on oxidative stress sensitivity in \u00df-thalassemia patients: an ancillary study of the ENERGIZE\/ENERGIZE-T clinical trials. Hemasphere. 2025;9(S1):3978\u20133980.","journal-title":"Hemasphere"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2212266"},{"issue":"1","key":"e_1_3_4_90_1","first-page":"457","article-title":"Etavopivat improves hemoglobin levels in adults and adolescents with non-transfusion-dependent alpha- or beta-thalassemia: results from the open-label phase 2 gladiolus study","volume":"10","author":"Sheth S","year":"2026","unstructured":"Sheth S, Kuo KHM, Kalfa TA, et al. Etavopivat improves hemoglobin levels in adults and adolescents with non-transfusion-dependent alpha- or beta-thalassemia: results from the open-label phase 2 gladiolus study. Hemasphere. 2026;10(S1):457\u2013458.","journal-title":"Hemasphere"}],"container-title":["Therapeutic Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20415990.2026.2742638","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/20415990.2026.2742638","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20415990.2026.2742638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:58:13Z","timestamp":1793109493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/20415990.2026.2742638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":88,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,2]]}},"alternative-id":["10.1080\/20415990.2026.2742638"],"URL":"https:\/\/doi.org\/10.1080\/20415990.2026.2742638","relation":{},"ISSN":["2041-5990","2041-6008"],"issn-type":[{"value":"2041-5990","type":"print"},{"value":"2041-6008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itde20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itde20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-07-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}